BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Crocetti L, de Baere T, Lencioni R. Quality improvement guidelines for radiofrequency ablation of liver tumours. Cardiovasc Intervent Radiol. 2010;33:11-17. [PMID: 19924474 DOI: 10.1007/s00270-009-9736-y] [Cited by in Crossref: 165] [Cited by in F6Publishing: 157] [Article Influence: 13.8] [Reference Citation Analysis]
Number Citing Articles
1 Felker ER, Lee-felker SA, Ajwichai K, Tan N, Lu DS, Durazo FA, Raman SS. Intraductal Cooling via a Nasobiliary Tube During Radiofrequency Ablation of Central Liver Tumors Reduces Biliary Injuries. American Journal of Roentgenology 2015;204:1329-35. [DOI: 10.2214/ajr.14.13788] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
2 Schmidt S, Follmann M, Malek N, Manns MP, Greten TF. Critical appraisal of clinical practice guidelines for diagnosis and treatment of hepatocellular carcinoma. J Gastroenterol Hepatol. 2011;26:1779-1786. [PMID: 21875430 DOI: 10.1111/j.1440-1746.2011.06891.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
3 Kattipatanapong T, Nishiofuku H, Tanaka T, Sato T, Masada T, Tatsumoto S, Matsumoto T, Kichikawa K. Improved Local Tumor Control and Survival Rates by Obtaining a 3D-Safety Margin in Superselective Transarterial Chemoembolization for Small Hepatocellular Carcinoma. Cardiovasc Intervent Radiol 2020;43:423-33. [DOI: 10.1007/s00270-019-02365-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Lencioni R, Cioni D. RFA plus lyso-thermosensitive liposomal doxorubicin: in search of the optimal approach to cure intermediate-size hepatocellular carcinoma. Hepat Oncol 2016;3:193-200. [PMID: 30191041 DOI: 10.2217/hep-2016-0005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
5 Dijkstra M, Nieuwenhuizen S, Puijk RS, Timmer FEF, Geboers B, Schouten EAC, Opperman J, Scheffer HJ, de Vries JJJ, Versteeg KS, Lissenberg-Witte BI, van den Tol MP, Meijerink MR. Primary Tumor Sidedness, RAS and BRAF Mutations and MSI Status as Prognostic Factors in Patients with Colorectal Liver Metastases Treated with Surgery and Thermal Ablation: Results from the Amsterdam Colorectal Liver Met Registry (AmCORE). Biomedicines 2021;9:962. [PMID: 34440165 DOI: 10.3390/biomedicines9080962] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Vogel A, Cervantes A, Chau I, Daniele B, Llovet JM, Meyer T, Nault JC, Neumann U, Ricke J, Sangro B, Schirmacher P, Verslype C, Zech CJ, Arnold D, Martinelli E;  ESMO Guidelines Committee. Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29:iv238-iv255. [PMID: 30285213 DOI: 10.1093/annonc/mdy308] [Cited by in Crossref: 230] [Cited by in F6Publishing: 204] [Article Influence: 76.7] [Reference Citation Analysis]
7 Lencioni R, Crocetti L. Local-regional treatment of hepatocellular carcinoma. Radiology. 2012;262:43-58. [PMID: 22190656 DOI: 10.1148/radiol.11110144] [Cited by in Crossref: 211] [Cited by in F6Publishing: 202] [Article Influence: 21.1] [Reference Citation Analysis]
8 De Cobelli F, Calandri M, Della Corte A, Sirovich R, Gazzera C, Della Vigna P, Bonomo G, Varano GM, Maiettini D, Mauri G, Camisassi N, Steidler S, Ratti F, Gusmini S, Ronzoni M, Aldrighetti L, Odisio BC, Racca P, Fonio P, Veltri A, Orsi F. Multi-institutional analysis of outcomes for thermosphere microwave ablation treatment of colorectal liver metastases: the SMAC study. Eur Radiol. [DOI: 10.1007/s00330-021-08497-2] [Reference Citation Analysis]
9 Vogl TJ, Farshid P, Naguib NN, Darvishi A, Bazrafshan B, Mbalisike E, Burkhard T, Zangos S. Thermal ablation of liver metastases from colorectal cancer: radiofrequency, microwave and laser ablation therapies. Radiol Med. 2014;119:451-461. [PMID: 24894923 DOI: 10.1007/s11547-014-0415-y] [Cited by in Crossref: 50] [Cited by in F6Publishing: 38] [Article Influence: 6.3] [Reference Citation Analysis]
10 Galanakis N, Kehagias E, Matthaiou N, Samonakis D, Tsetis D. Transcatheter arterial chemoembolization combined with radiofrequency or microwave ablation for hepatocellular carcinoma: a review. Hepat Oncol 2018;5:HEP07. [PMID: 31293775 DOI: 10.2217/hep-2018-0001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
11 Proschek D, Tonak M, Zangos S, Mack MG, Kurth AA. Radiofrequency ablation in experimental bone metastases using a controlled and navigated ablation device. J Bone Oncol 2012;1:63-6. [PMID: 26909257 DOI: 10.1016/j.jbo.2012.07.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
12 Stintzing S, Grothe A, Hendrich S, Hoffmann RT, Heinemann V, Rentsch M, Fuerweger C, Muacevic A, Trumm CG. Percutaneous radiofrequency ablation (RFA) or robotic radiosurgery (RRS) for salvage treatment of colorectal liver metastases. Acta Oncol. 2013;52:971-977. [PMID: 23409768 DOI: 10.3109/0284186x.2013.766362] [Cited by in Crossref: 33] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
13 Vouche M, Habib A, Ward TJ, Kim E, Kulik L, Ganger D, Mulcahy M, Baker T, Abecassis M, Sato KT, Caicedo JC, Fryer J, Hickey R, Hohlastos E, Lewandowski RJ, Salem R. Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: multicenter radiology-pathology correlation and survival of radiation segmentectomy. Hepatology. 2014;60:192-201. [PMID: 24691943 DOI: 10.1002/hep.27057] [Cited by in Crossref: 141] [Cited by in F6Publishing: 120] [Article Influence: 17.6] [Reference Citation Analysis]
14 Chang W, Lee JM, Yoon JH, Lee DH, Lee SM, Lee KB, Kim BR, Kim TH, Lee S, Han JK. No-touch radiofrequency ablation using multiple electrodes: An in vivo comparison study of switching monopolar versus switching bipolar modes in porcine livers. PLoS One 2017;12:e0176350. [PMID: 28445542 DOI: 10.1371/journal.pone.0176350] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
15 Smolock AR, Shaw C. Hepatic Microwave Ablation in Challenging Locations. Semin Intervent Radiol 2019;36:392-7. [PMID: 31798213 DOI: 10.1055/s-0039-1697003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
16 Peng S, Huang P, Yu H, Wen Y, Luo Y, Wang X, Zhou J, Qin S, Li T, Chen Y, Liu G, Huang M. Prognostic value of carcinoembryonic antigen level in patients with colorectal cancer liver metastasis treated with percutaneous microwave ablation under ultrasound guidance. Medicine (Baltimore) 2018;97:e0044. [PMID: 29517661 DOI: 10.1097/MD.0000000000010044] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Kasivisvanathan V, Thapar A, Oskrochi Y, Picard J, Leen EL. Irreversible electroporation for focal ablation at the porta hepatis. Cardiovasc Intervent Radiol 2012;35:1531-4. [PMID: 22367010 DOI: 10.1007/s00270-012-0363-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
18 Meijerink MR, van den Tol MP, Puijk RS. The rapidly expanding role of thermal ablation in the treatment of colorectal liver metastases. Hepatobiliary Surg Nutr 2020;9:522-5. [PMID: 32832509 DOI: 10.21037/hbsn.2019.11.22] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Zorbas G, Samaras T. Simulation of radiofrequency ablation in real human anatomy. International Journal of Hyperthermia 2014;30:570-8. [DOI: 10.3109/02656736.2014.968639] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
20 Lencioni R. Loco-regional treatment of hepatocellular carcinoma. Hepatology 2010;52:762-73. [DOI: 10.1002/hep.23725] [Cited by in Crossref: 323] [Cited by in F6Publishing: 320] [Article Influence: 26.9] [Reference Citation Analysis]
21 Yoon JH, Lee JM, Woo S, Hwang EJ, Hwang I, Choi W, Han JK, Choi BI. Switching bipolar hepatic radiofrequency ablation using internally cooled wet electrodes: comparison with consecutive monopolar and switching monopolar modes. Br J Radiol 2015;88:20140468. [PMID: 25873479 DOI: 10.1259/bjr.20140468] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
22 Lencioni R, de Baere T, Martin RC, Nutting CW, Narayanan G. Image-Guided Ablation of Malignant Liver Tumors: Recommendations for Clinical Validation of Novel Thermal and Non-Thermal Technologies - A Western Perspective. Liver Cancer 2015;4:208-14. [PMID: 26734576 DOI: 10.1159/000367747] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 5.9] [Reference Citation Analysis]
23 Koda M, Murawaki Y, Hirooka Y, Kitamoto M, Ono M, Sakaeda H, Joko K, Sato S, Tamaki K, Yamasaki T, Shibata H, Shimoe T, Matsuda T, Toshikuni N, Fujioka S, Ohmoto K, Nakamura S, Kariyama K, Aikata H, Kobayashi Y, Tsutsui A. Complications of radiofrequency ablation for hepatocellular carcinoma in a multicenter study: An analysis of 16 346 treated nodules in 13 283 patients: Complications of RFA for HCC. Hepatology Research 2012;42:1058-64. [DOI: 10.1111/j.1872-034x.2012.01025.x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 34] [Article Influence: 6.5] [Reference Citation Analysis]
24 Adam A, Kenny LM. Interventional oncology in multidisciplinary cancer treatment in the 21(st) century. Nat Rev Clin Oncol 2015;12:105-13. [PMID: 25445561 DOI: 10.1038/nrclinonc.2014.211] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
25 Li WH, Ma KW, Cheng M, Chui KH, Chan PT, Chu WH, Fung HS, Kowk CH, Cheung MT. Radiofrequency ablation for hepatocellular carcinoma: a survival analysis of 117 patients. ANZ J Surg 2010;80:714-21. [PMID: 21040332 DOI: 10.1111/j.1445-2197.2010.05434.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
26 Bretschneider T, Ricke J, Gebauer B, Streitparth F. Image-guided high-dose-rate brachytherapy of malignancies in various inner organs - technique, indications, and perspectives. J Contemp Brachytherapy 2016;8:251-61. [PMID: 27504135 DOI: 10.5114/jcb.2016.61068] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
27 Wang F, Xu C, Li G, Lv P, Gu J. Incomplete radiofrequency ablation induced chemoresistance by up-regulating heat shock protein 70 in hepatocellular carcinoma. Exp Cell Res 2021;409:112910. [PMID: 34801560 DOI: 10.1016/j.yexcr.2021.112910] [Reference Citation Analysis]
28 Gillies DJ, Bax J, Barker K, Gardi L, Kakani N, Fenster A. Geometrically variable three-dimensional ultrasound for mechanically assisted image-guided therapy of focal liver cancer tumors. Med Phys 2020;47:5135-46. [PMID: 32686142 DOI: 10.1002/mp.14405] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Reinhardt M, Brandmaier P, Seider D, Kolesnik M, Jenniskens S, Sequeiros RB, Eibisberger M, Voglreiter P, Flanagan R, Mariappan P, Busse H, Moche M; ClinicIMPPACT Study Group. A prospective development study of software-guided radio-frequency ablation of primary and secondary liver tumors: Clinical intervention modelling, planning and proof for ablation cancer treatment (ClinicIMPPACT). Contemp Clin Trials Commun 2017;8:25-32. [PMID: 29696193 DOI: 10.1016/j.conctc.2017.08.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
30 Tanis E, Spliethoff J, Evers D, Langhout G, Snaebjornsson P, Prevoo W, Hendriks B, Ruers T. Real-time in vivo assessment of radiofrequency ablation of human colorectal liver metastases using diffuse reflectance spectroscopy. European Journal of Surgical Oncology (EJSO) 2016;42:251-9. [DOI: 10.1016/j.ejso.2015.12.005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
31 Shyn PB, Casadaban LC, Sainani NI, Sadow CA, Bunch PM, Levesque VM, Kim CK, Gerbaudo VH, Silverman SG. Intraprocedural Ablation Margin Assessment by Using Ammonia Perfusion PET during FDG PET/CT–guided Liver Tumor Ablation: A Pilot Study. Radiology 2018;288:138-45. [DOI: 10.1148/radiol.2018172108] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
32 McLoney ED, Isaacson AJ, Keating P. The Role of PET Imaging Before, During, and After Percutaneous Hepatic and Pulmonary Tumor Ablation. Semin Intervent Radiol 2014;31:187-92. [PMID: 25049446 DOI: 10.1055/s-0034-1373793] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
33 Hendriks P, Noortman WA, Baetens TR, van Erkel AR, van Rijswijk CSP, van der Meer RW, Coenraad MJ, de Geus-Oei LF, Slump CH, Burgmans MC. Quantitative Volumetric Assessment of Ablative Margins in Hepatocellular Carcinoma: Predicting Local Tumor Progression Using Nonrigid Registration Software. J Oncol 2019;2019:4049287. [PMID: 31641353 DOI: 10.1155/2019/4049287] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
34 Patel PA, Ingram L, Wilson ID, Breen DJ. No-touch Wedge Ablation Technique of Microwave Ablation for the Treatment of Subcapsular Tumors in the Liver. Journal of Vascular and Interventional Radiology 2013;24:1257-62. [DOI: 10.1016/j.jvir.2013.04.014] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
35 Dakua SP, Nayak A. A review on treatments of hepatocellular carcinoma—role of radio wave ablation and possible improvements. Egypt Liver Journal 2022;12. [DOI: 10.1186/s43066-022-00191-2] [Reference Citation Analysis]
36 Deng H, Zhang T, Jiang X, Huang S, Jiang NN, Lau WY, Jinhua H. Comparison of hydrochloric acid infusion radiofrequency ablation with microwave ablation in an ex vivo liver model. Int J Hyperthermia 2020;37:600-7. [PMID: 32484363 DOI: 10.1080/02656736.2020.1772995] [Reference Citation Analysis]
37 Guo H, Huang J, Tan Y, Wu W, Huang T, Zhang N, Chen S, Zhang C, Xie X, Shuai X, Xu M. Nanodrug shows spatiotemporally controlled release of anti-PD-L1 antibody and STING agonist to effectively inhibit tumor progression after radiofrequency ablation. Nano Today 2022;43:101425. [DOI: 10.1016/j.nantod.2022.101425] [Reference Citation Analysis]
38 Kovács A, Iezzi R, Cellini F, Lancellotta V, Bischoff P, Carchesio F, Tagliaferri L, Kovács G, Gambacorta MA. Critical review of multidisciplinary non-surgical local interventional ablation techniques in primary or secondary liver malignancies. J Contemp Brachytherapy 2019;11:589-600. [PMID: 31969919 DOI: 10.5114/jcb.2019.90466] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
39 Foltz G. Image-guided percutaneous ablation of hepatic malignancies. Semin Intervent Radiol. 2014;31:180-186. [PMID: 25071304 DOI: 10.1055/s-0034-1373792] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
40 Nazzal M, Gadani S, Said A, Rice M, Okoye O, Taha A, Lentine K. Liver targeted therapies for hepatocellular carcinoma prior to transplant: contemporary management strategies. Glob Surg 2017;3. [DOI: 10.15761/gos.1000171] [Reference Citation Analysis]
41 Yaghmai V, Besa C, Kim E, Gatlin JL, Siddiqui NA, Taouli B. Imaging Assessment of Hepatocellular Carcinoma Response to Locoregional and Systemic Therapy. American Journal of Roentgenology 2013;201:80-96. [DOI: 10.2214/ajr.13.10706] [Cited by in Crossref: 53] [Cited by in F6Publishing: 18] [Article Influence: 5.9] [Reference Citation Analysis]
42 Chai NX, Chapiro J, Petukhova A, Gross M, Kucukkaya A, Raju R, Zeevi T, Elbanan M, Lin M, Perez-Lozada JC, Schlachter T, Strazzabosco M, Pollak JS, Madoff DC. Thermal ablation alone vs thermal ablation combined with transarterial chemoembolization for patients with small (<3 cm) hepatocellular carcinoma. Clin Imaging 2021;76:123-9. [PMID: 33592550 DOI: 10.1016/j.clinimag.2021.01.043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
43 Samim M, Molenaar IQ, Seesing MFJ, van Rossum PSN, van den Bosch MAAJ, Ruers TJM, Borel Rinkes IHM, van Hillegersberg R, Lam MGEH, Verkooijen HM. The diagnostic performance of 18F-FDG PET/CT, CT and MRI in the treatment evaluation of ablation therapy for colorectal liver metastases: A systematic review and meta-analysis. Surg Oncol 2017;26:37-45. [PMID: 28317583 DOI: 10.1016/j.suronc.2016.12.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
44 Crocetti L, Della Pina C, Cioni D, Lencioni R. Peri-intraprocedural imaging: US, CT, and MRI. Abdom Imaging 2011;36:648-60. [DOI: 10.1007/s00261-011-9750-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
45 Widmann G, Schullian P, Haidu M, Bale R. Stereotactic radiofrequency ablation (SRFA) of liver lesions: technique effectiveness, safety, and interoperator performance. Cardiovasc Intervent Radiol 2012;35:570-80. [PMID: 21671150 DOI: 10.1007/s00270-011-0200-4] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
46 Dietrich CF, Müller T, Bojunga J, Dong Y, Mauri G, Radzina M, Dighe M, Cui X, Grünwald F, Schuler A, Ignee A, Korkusuz H. Statement and Recommendations on Interventional Ultrasound as a Thyroid Diagnostic and Treatment Procedure. Ultrasound in Medicine & Biology 2018;44:14-36. [DOI: 10.1016/j.ultrasmedbio.2017.08.1889] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 12.0] [Reference Citation Analysis]
47 Iguchi T, Inoue D, Yabushita K, Sakaguchi K, Tatsukawa M, Sasaki H, Kanazawa S. Effect of CT fluoroscopy-guided transpulmonary radiofrequency ablation of liver tumours on the lung. Br J Radiol. 2012;85:e373-e377. [PMID: 22374277 DOI: 10.1259/bjr/34646739] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
48 McDermott S, Gervais DA. Radiofrequency ablation of liver tumors. Semin Intervent Radiol. 2013;30:49-55. [PMID: 24436517 DOI: 10.1055/s-0033-1333653] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 6.3] [Reference Citation Analysis]
49 Crocetti L, Lencioni R. Radiofrequency ablation of pulmonary tumors. Eur J Radiol. 2010;75:23-27. [PMID: 20452739 DOI: 10.1016/j.ejrad.2010.04.011] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
50 Wendler JJ, Fischbach K, Ricke J, Jürgens J, Fischbach F, Köllermann J, Porsch M, Baumunk D, Schostak M, Liehr UB, Pech M. Irreversible Electroporation (IRE): Standardization of Terminology and Reporting Criteria for Analysis and Comparison. Pol J Radiol 2016;81:54-64. [PMID: 26966472 DOI: 10.12659/PJR.896034] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
51 Lin CC, Chen TH, Wu YC, Fang CY, Wang JY, Chen CP, Huang KW, Jiang JK. Taiwan Society of Colon and Rectal Surgeons (TSCRS) Consensus for Cytoreduction Selection in Metastatic Colorectal Cancer. Ann Surg Oncol 2021;28:1762-76. [PMID: 32875464 DOI: 10.1245/s10434-020-08914-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
52 Chun JY, Ho CS. Management of Pericardial Effusion following Cardiac Perforation during Radiofrequency Ablation of Hepatocellular Carcinoma. Semin Intervent Radiol 2014;31:101-3. [PMID: 24596447 DOI: 10.1055/s-0033-1363850] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
53 Dijkstra M, Nieuwenhuizen S, Puijk RS, Timmer FEF, Geboers B, Schouten EAC, Opperman J, Scheffer HJ, Vries JJJ, Swijnenburg RJ, Versteeg KS, Lissenberg-Witte BI, van den Tol MP, Meijerink MR. Thermal Ablation Compared to Partial Hepatectomy for Recurrent Colorectal Liver Metastases: An Amsterdam Colorectal Liver Met Registry (AmCORE) Based Study. Cancers (Basel) 2021;13:2769. [PMID: 34199556 DOI: 10.3390/cancers13112769] [Reference Citation Analysis]
54 Collettini F, Schnapauff D, Poellinger A, Denecke T, Schott E, Berg T, Wust P, Hamm B, Gebauer B. Hepatocellular carcinoma: computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of large (5-7 cm) and very large (>7 cm) tumours. Eur Radiol 2012;22:1101-9. [PMID: 22173693 DOI: 10.1007/s00330-011-2352-7] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
55 Ma Y, Chen Z, Zhu W, Yu J, Ji H, Tang X, Yu H, Fan L, Liang B, Li R, Li J, Li Z, Lin M, Niu L. Chemotherapy plus concurrent irreversible electroporation improved local tumor control in unresectable hilar cholangiocarcinoma compared with chemotherapy alone. Int J Hyperthermia 2021;38:1512-8. [PMID: 34767740 DOI: 10.1080/02656736.2021.1991008] [Reference Citation Analysis]
56 Eriguchi T, Takeda A, Tateishi Y, Tsurugai Y, Sanuki N, Ebinuma H, Horita N. Comparison of stereotactic body radiotherapy and radiofrequency ablation for hepatocellular carcinoma: Systematic review and meta-analysis of propensity score studies. Hepatol Res 2021;51:813-22. [PMID: 33856722 DOI: 10.1111/hepr.13647] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Muñoz NM, Dupuis C, Williams M, Dixon K, McWatters A, Avritscher R, Bouchard R, Kaseb A, Schachtschneider KM, Rao A, Sheth RA. Molecularly targeted photothermal ablation improves tumor specificity and immune modulation in a rat model of hepatocellular carcinoma. Commun Biol 2020;3:783. [PMID: 33335270 DOI: 10.1038/s42003-020-01522-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
58 Puijk RS, Ruarus AH, Scheffer HJ, Vroomen LGPH, van Tilborg AAJM, de Vries JJJ, Berger FH, van den Tol PMP, Meijerink MR. Percutaneous Liver Tumour Ablation: Image Guidance, Endpoint Assessment, and Quality Control. Can Assoc Radiol J 2018;69:51-62. [PMID: 29458955 DOI: 10.1016/j.carj.2017.11.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
59 Abbas H, Erridge S, Sodergren MH, Papoulas M, Nawaz A, Menon K, Heaton ND, Prachalias AA, Srinivasan P. Breast cancer liver metastases in a UK tertiary centre: Outcomes following referral to tumour board meeting. International Journal of Surgery 2017;44:152-9. [DOI: 10.1016/j.ijsu.2017.06.049] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
60 Dollinger M, Zeman F, Niessen C, Lang SA, Beyer LP, Müller M, Stroszczynski C, Wiggermann P. Bile Duct Injury after Irreversible Electroporation of Hepatic Malignancies: Evaluation of MR Imaging Findings and Laboratory Values. J Vasc Interv Radiol 2016;27:96-103. [PMID: 26777402 DOI: 10.1016/j.jvir.2015.10.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
61 Volpi S, Tsoumakidou G, Loriaud A, Hocquelet A, Duran R, Denys A. Electromagnetic navigation system combined with High-Frequency-Jet-Ventilation for CT-guided hepatic ablation of small US-Undetectable and difficult to access lesions. International Journal of Hyperthermia 2019;36:1050-6. [DOI: 10.1080/02656736.2019.1671612] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
62 Kawamura R, Seki T, Umehara H, Ikeda K, Inokuchi R, Asayama T, Yamaguchi T, Takahashi Y, Sakao M, Lencioni R. Combined treatment of large hepatocellular carcinoma with transcatheter arterial chemoembolization and percutaneous ethanol injection with a multipronged needle: experimental and clinical investigation. Cardiovasc Intervent Radiol. 2012;35:325-333. [PMID: 21607824 DOI: 10.1007/s00270-011-0184-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
63 Zhang ZM, Guo JX, Zhang ZC, Jiang N, Zhang ZY, Pan LJ. Therapeutic options for intermediate-advanced hepatocellular carcinoma. World J Gastroenterol 2011;17:1685-9. [PMID: 21483627 DOI: 10.3748/wjg.v17.i13.1685] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
64 Bäumler W, Sebald M, Einspieler I, Wiggermann P, Schicho A, Schaible J, Lürken L, Dollinger M, Stroszczynski C, Beyer LP. Incidence and evolution of venous thrombosis during the first 3 months after irreversible electroporation of malignant hepatic tumours. Sci Rep 2019;9:19876. [PMID: 31882716 DOI: 10.1038/s41598-019-56324-y] [Reference Citation Analysis]
65 Silk MT, Wimmer T, Lee KS, Srimathveeravalli G, Brown KT, Kingham PT, Fong Y, Durack JC, Sofocleous CT, Solomon SB. Percutaneous ablation of peribiliary tumors with irreversible electroporation. J Vasc Interv Radiol. 2014;25:112-118. [PMID: 24262034 DOI: 10.1016/j.jvir.2013.10.012] [Cited by in Crossref: 86] [Cited by in F6Publishing: 84] [Article Influence: 9.6] [Reference Citation Analysis]
66 Viganò L, Laurenzi A, Solbiati L, Procopio F, Cherqui D, Torzilli G. Open Liver Resection, Laparoscopic Liver Resection, and Percutaneous Thermal Ablation for Patients with Solitary Small Hepatocellular Carcinoma (≤30 mm): Review of the Literature and Proposal for a Therapeutic Strategy. Dig Surg 2018;35:359-71. [PMID: 29890512 DOI: 10.1159/000489836] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
67 Mok PS, Tan EY, Baerlocher MO, Athreya S. The role of morbidity and mortality meetings in interventional radiology. Eur J Radiol 2012;81:3344-7. [PMID: 22297187 DOI: 10.1016/j.ejrad.2012.01.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
68 Di Martino M, Rompianesi G, Mora-Guzmán I, Martín-Pérez E, Montalti R, Troisi RI. Systematic review and meta-analysis of local ablative therapies for resectable colorectal liver metastases. Eur J Surg Oncol 2020;46:772-81. [PMID: 31862133 DOI: 10.1016/j.ejso.2019.12.003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
69 Sotirchos VS, Petrovic LM, Gönen M, Klimstra DS, Do RK, Petre EN, Garcia AR, Barlas A, Erinjeri JP, Brown KT, Covey AM, Alago W, Brody LA, DeMatteo RP, Kemeny NE, Solomon SB, Manova-Todorova KO, Sofocleous CT. Colorectal Cancer Liver Metastases: Biopsy of the Ablation Zone and Margins Can Be Used to Predict Oncologic Outcome. Radiology 2016;280:949-59. [PMID: 27010254 DOI: 10.1148/radiol.2016151005] [Cited by in Crossref: 64] [Cited by in F6Publishing: 59] [Article Influence: 10.7] [Reference Citation Analysis]
70 Georgakopoulos A, Pianou N, Kelekis N, Chatziioannou S. Impact of 18F-FDG PET/CT on therapeutic decisions in patients with colorectal cancer and liver metastases. Clinical Imaging 2013;37:536-41. [DOI: 10.1016/j.clinimag.2012.09.011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
71 Bäumler W, Beyer LP, Lürken L, Wiggermann P, Stroszczynski C, Dollinger M, Schicho A. Detection of Incomplete Irreversible Electroporation (IRE) and Microwave Ablation (MWA) of Hepatocellular Carcinoma (HCC) Using Iodine Quantification in Dual Energy Computed Tomography (DECT). Diagnostics 2022;12:986. [DOI: 10.3390/diagnostics12040986] [Reference Citation Analysis]
72 Chang XW, Ma XX, Zhu RT, Li J. Imaging evaluation of residual cancer after radiofrequency ablation of hepatocellular carcinoma. Shijie Huaren Xiaohua Zazhi 2016; 24(10): 1539-1544 [DOI: 10.11569/wcjd.v24.i10.1539] [Reference Citation Analysis]
73 Hompes D, Prevoo W, Ruers T. Radiofrequency ablation as a treatment tool for liver metastases of colorectal origin. Cancer Imaging 2011;11:23-30. [PMID: 21435988 DOI: 10.1102/1470-7330.2011.0004] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
74 Wang Y, Luo Q, Li Y, Deng S, Li X, Wei S. A systematic assessment of the quality of systematic reviews/meta-analyses in radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma: Quality assessment for small HCC. Journal of Evidence-Based Medicine 2014;7:103-20. [DOI: 10.1111/jebm.12100] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
75 Bäumler W, Wiggermann P, Lürken L, Dollinger M, Stroszczynski C, Beyer LP, Schicho A. Early Detection of Local Tumor Progression after Irreversible Electroporation (IRE) of a Hepatocellular Carcinoma Using Gd-EOB-DTPA-Based MR Imaging at 3T. Cancers (Basel) 2021;13:1595. [PMID: 33808336 DOI: 10.3390/cancers13071595] [Reference Citation Analysis]
76 Bertot LC, Sato M, Tateishi R, Yoshida H, Koike K. Mortality and complication rates of percutaneous ablative techniques for the treatment of liver tumors: a systematic review. Eur Radiol. 2011;21:2584-2596. [PMID: 21858539 DOI: 10.1007/s00330-011-2222-3] [Cited by in Crossref: 91] [Cited by in F6Publishing: 87] [Article Influence: 8.3] [Reference Citation Analysis]
77 Lewis S, Barry A, Hawkins M. Hypofractionation in Hepatocellular Carcinoma – The Effect of Fractionation Size. Clinical Oncology 2022. [DOI: 10.1016/j.clon.2022.02.021] [Reference Citation Analysis]
78 Boonsirikamchai P, Loyer EM, Choi H, Charnsangavej C. Planning and follow-up after ablation of hepatic tumors: imaging evaluation. Surg Oncol Clin N Am. 2011;20:301-15, viii. [PMID: 21377585 DOI: 10.1016/j.soc.2010.11.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
79 Wang X, Sofocleous CT, Erinjeri JP, Petre EN, Gonen M, Do KG, Brown KT, Covey AM, Brody LA, Alago W, Thornton RH, Kemeny NE, Solomon SB. Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastases. Cardiovasc Intervent Radiol. 2013;36:166-175. [PMID: 22535243 DOI: 10.1007/s00270-012-0377-1] [Cited by in Crossref: 160] [Cited by in F6Publishing: 159] [Article Influence: 16.0] [Reference Citation Analysis]
80 Bergamini C, Cavalieri S, Cascella T, Lanocita R, Alfieri S, Resteghini C, Platini F, Orlandi E, Locati LD, Marchianò A, Licitra L. Local therapies for liver metastases of rare head and neck cancers: a monoinstitutional case series. Tumori 2021;107:188-95. [PMID: 32924878 DOI: 10.1177/0300891620952844] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
81 Samim M, El-Haddad GE, Molenaar IQ, Prevoo W, van den Bosch MA, Alavi A, Lam MG. [18F]Fluorodeoxyglucose PET for Interventional Oncology in Liver Malignancy. PET Clin 2014;9:469-95, vi. [PMID: 26050948 DOI: 10.1016/j.cpet.2014.07.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
82 Lencioni R, Crocetti L. Image-guided ablation for hepatocellular carcinoma. Recent Results Cancer Res. 2013;190:181-194. [PMID: 22941021 DOI: 10.1007/978-3-642-16037-0_12] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
83 Swersky A, Kulik L, Kalyan A, Grace K, Caicedo JC, Lewandowski RJ, Salem R. Contemporary Algorithm for the Management of Hepatocellular Carcinoma in 2021: The Northwestern Approach. Semin Intervent Radiol 2021;38:432-7. [PMID: 34629710 DOI: 10.1055/s-0041-1735528] [Reference Citation Analysis]
84 Rosenberg C, Jahn A, Pickartz T, Wahnschaffe U, Patrzyk M, Hosten N. Gd-EOB-DTPA-enhanced MR guidance in thermal ablation of liver malignancies. PLoS One 2014;9:e109217. [PMID: 25541950 DOI: 10.1371/journal.pone.0109217] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
85 Wimmer T, Srimathveeravalli G, Gutta N, Ezell PC, Monette S, Kingham TP, Maybody M, Durack JC, Fong Y, Solomon SB. Comparison of simulation-based treatment planning with imaging and pathology outcomes for percutaneous CT-guided irreversible electroporation of the porcine pancreas: a pilot study. J Vasc Interv Radiol 2013;24:1709-18. [PMID: 23891044 DOI: 10.1016/j.jvir.2013.05.056] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
86 Pohlman RM, Hinshaw JL, Ziemlewicz TJ, Lubner MG, Wells SA, Lee FT Jr, Alexander ML, Wergin KL, Varghese T. Differential Imaging of Liver Tumors before and after Microwave Ablation with Electrode Displacement Elastography. Ultrasound Med Biol 2021;47:2138-56. [PMID: 34011451 DOI: 10.1016/j.ultrasmedbio.2021.03.027] [Reference Citation Analysis]
87 Raissi D, Sanampudi S, Yu Q, Winkler M. CT-guided microwave ablation of hepatic malignancies via transpulmonary approach without ancillary techniques. JCIS 2022;12:2. [DOI: 10.25259/jcis_152_2021] [Reference Citation Analysis]
88 Herbold T, Wahba R, Bangard C, Demir M, Drebber U, Stippel DL. The laparoscopic approach for radiofrequency ablation of hepatocellular carcinoma—indication, technique and results. Langenbecks Arch Surg 2013;398:47-53. [DOI: 10.1007/s00423-012-1018-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
89 Spinczyk D, Badura A, Sperka P, Stronczek M, Pyciński B, Juszczyk J, Czajkowska J, Biesok M, Rudzki M, Więcławek W, Zarychta P, Badura P, Woloshuk A, Żyłkowski J, Rosiak G, Konecki D, Milczarek K, Rowiński O, Piętka E. Supporting diagnostics and therapy planning for percutaneous ablation of liver and abdominal tumors and pre-clinical evaluation. Computerized Medical Imaging and Graphics 2019;78:101664. [DOI: 10.1016/j.compmedimag.2019.101664] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
90 Odisio BC, Richter M, Aloia TA, Conrad C, Ahrar K, Gupta S, Vauthey JN, Huang SY. Use of Prophylactic Antibiotics to Prevent Abscess Formation Following Hepatic Ablation in Patients with Prior Enterobiliary Manipulation. J Gastrointest Surg 2016;20:1428-34. [PMID: 26984694 DOI: 10.1007/s11605-016-3117-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
91 Lee DH, Lee JM, Lee JY, Kim SH, Han JK, Choi BI. Radiofrequency ablation for intrahepatic recurrent hepatocellular carcinoma: long-term results and prognostic factors in 168 patients with cirrhosis. Cardiovasc Intervent Radiol 2014;37:705-15. [PMID: 23912493 DOI: 10.1007/s00270-013-0708-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
92 Vernaleone M, Bonomo P, Di Cataldo V, Saieva C, Masi L, Desideri I, Greto D, Francolini G, Becherini C, Livi L. Robotic stereotactic radiotherapy for liver oligometastases from colorectal cancer: a single-center experience. Radiol Med 2019;124:870-6. [PMID: 31104277 DOI: 10.1007/s11547-019-01042-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
93 Barzakova E, Senthilvel N, Bruners P, Keil S, Lurje G, Zimmermann M, Kuhl CK, Isfort P. Detectability of Target Lesion During CT-Guided Tumor Ablations: Impact on Ablation Outcome. Rofo 2021. [PMID: 34794185 DOI: 10.1055/a-1669-9342] [Reference Citation Analysis]
94 Xu Z, Xie H, Zhou L, Chen X, Zheng S. The Combination Strategy of Transarterial Chemoembolization and Radiofrequency Ablation or Microwave Ablation against Hepatocellular Carcinoma. Anal Cell Pathol (Amst) 2019;2019:8619096. [PMID: 31534899 DOI: 10.1155/2019/8619096] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
95 Majdalany BS, Willatt J, Chick JFB, Srinivasa RN, Saad WA. Fibrillar collagen injection for organ protection during thermal ablation of hepatic malignancies. Diagn Interv Radiol 2017;23:381-4. [PMID: 28836494 DOI: 10.5152/dir.2017.17120] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
96 Sabrina V, Michael B, Jörg A, Peter B, Wolf B, Susanne B, Thomas B, Frank D, Matthias E, Markus F, Christian F, Paul F, Andreas G, Eleni G, Martin G, Elke H, Thomas H, Ralf-Thorsten H, Wolf-Peter H, Peter H, Achim K, Gabi K, Jürgen K, David K, Frank L, Hauke L, Thomas L, Philipp L, Andreas M, Alexander M, Oliver M, Silvio N, Huu Phuc N, Johann O, Karl-Jürgen O, Philipp P, Kerstin P, Philippe P, Thorsten P, Mathias P, Ruben P, Jürgen P, Jutta R, Peter R, Johanna R, Ulrike R, Elke R, Barbara S, Peter S, Irene S, Andreas S, Dietrich VS, Daniel S, Marianne S, Alexander S, Andreas S, Nadine S, Christian S, Andrea T, Anne T, Jörg T, Ingo VT, Reina T, Arndt V, Thomas V, Hilke V, Frank W, Oliver W, Heiner W, Henning W, Dane W, Christian W, Marcus-Alexander W, Peter G, Nisar M. S3-Leitlinie: Diagnostik und Therapie des hepatozellulären Karzinoms. Z Gastroenterol 2022;60:e56-e130. [PMID: 35042248 DOI: 10.1055/a-1589-7568] [Reference Citation Analysis]
97 Peungjesada S, Chuang HH, Prasad SR, Choi H, Loyer EM, Bronstein Y. Evaluation of cancer treatment in the abdomen: Trends and advances. World J Radiol 2013; 5(3): 126-142 [PMID: 23671749 DOI: 10.4329/wjr.v5.i3.126] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
98 Vogl TJ, Farshid P, Naguib NN, Zangos S. Thermal ablation therapies in patients with breast cancer liver metastases: a review. Eur Radiol 2013;23:797-804. [PMID: 23064713 DOI: 10.1007/s00330-012-2662-4] [Cited by in Crossref: 32] [Cited by in F6Publishing: 40] [Article Influence: 3.2] [Reference Citation Analysis]
99 Alonzo M, Bos A, Bennett S, Ferral H. The Emprint™ Ablation System with Thermosphere™ Technology: One of the Newer Next-Generation Microwave Ablation Technologies. Semin Intervent Radiol 2015;32:335-8. [PMID: 26622094 DOI: 10.1055/s-0035-1564811] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 4.4] [Reference Citation Analysis]
100 Liang PC, Lai HS, Shih TT, Wu CH, Huang KW. The pilot experience upon surgical ablation of large liver tumor by microwave system with tissue permittivity feedback control mechanism. BMC Surg. 2014;14:82. [PMID: 25336074 DOI: 10.1186/1471-2482-14-82] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
101 Cho HJ, Kim JK, Nam JS, Wang HJ, Lee JH, Kim BW, Kim SS, Noh CK, Shin SJ, Lee KM, Cho SW, Cheong JY. High circulating microRNA-122 expression is a poor prognostic marker in patients with hepatitis B virus-related hepatocellular carcinoma who undergo radiofrequency ablation. Clinical Biochemistry 2015;48:1073-8. [DOI: 10.1016/j.clinbiochem.2015.06.019] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 4.9] [Reference Citation Analysis]
102 Nieuwenhuizen S, Puijk RS, van den Bemd B, Aldrighetti L, Arntz M, van den Boezem PB, Bruynzeel AME, Burgmans MC, de Cobelli F, Coolsen MME, Dejong CHC, Derks S, Diederik A, van Duijvendijk P, Eker HH, Engelsman AF, Erdmann JI, Fütterer JJ, Geboers B, Groot G, Haasbeek CJA, Janssen JJ, de Jong KP, Kater GM, Kazemier G, Kruimer JWH, Leclercq WKG, van der Leij C, Manusama ER, Meier MAJ, van der Meijs BB, Melenhorst MCAM, Nielsen K, Nijkamp MW, Potters FH, Prevoo W, Rietema FJ, Ruarus AH, Ruiter SJS, Schouten EAC, Serafino GP, Sietses C, Swijnenburg RJ, Timmer FEF, Versteeg KS, Vink T, de Vries JJJ, de Wilt JHW, Zonderhuis BM, Scheffer HJ, van den Tol PMP, Meijerink MR. Resectability and Ablatability Criteria for the Treatment of Liver Only Colorectal Metastases: Multidisciplinary Consensus Document from the COLLISION Trial Group.Cancers (Basel). 2020;12. [PMID: 32635230 DOI: 10.3390/cancers12071779] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
103 Petit A, Hocquelet A, N'kontchou G, Varin E, Sellier N, Seror O, Sutter O. No-Touch Multi-bipolar Radiofrequency Ablation for the Treatment of Subcapsular Hepatocellular Carcinoma ≤ 5 cm Not Puncturable via the Non-tumorous Liver Parenchyma. Cardiovasc Intervent Radiol 2020;43:273-83. [PMID: 31673728 DOI: 10.1007/s00270-019-02357-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
104 Kelekis A, Filippiadis D. Computed Tomography and Ultrasounds for the Follow-up of Hepatocellular Carcinoma Ablation: What You Need to Know. Diagnostics (Basel) 2016;6:E9. [PMID: 26861398 DOI: 10.3390/diagnostics6010009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
105 Crocetti L, de Baére T, Pereira PL, Tarantino FP. CIRSE Standards of Practice on Thermal Ablation of Liver Tumours. Cardiovasc Intervent Radiol 2020;43:951-62. [PMID: 32382856 DOI: 10.1007/s00270-020-02471-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
106 Ruers T, Van Coevorden F, Punt CJ, Pierie JE, Borel-Rinkes I, Ledermann JA, Poston G, Bechstein W, Lentz MA, Mauer M, Folprecht G, Van Cutsem E, Ducreux M, Nordlinger B; European Organisation for Research and Treatment of Cancer (EORTC); Gastro-Intestinal Tract Cancer Group; Arbeitsgruppe Lebermetastasen und tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO); National Cancer Research Institute Colorectal Clinical Study Group (NCRI CCSG). Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial. J Natl Cancer Inst. 2017;109. [PMID: 28376151 DOI: 10.1093/jnci/djx015] [Cited by in Crossref: 197] [Cited by in F6Publishing: 192] [Article Influence: 39.4] [Reference Citation Analysis]
107 Puijk RS, Nieuwenhuizen S, van den Bemd BAT, Ruarus AH, Geboers B, Vroomen LGPH, Muglia R, de Jong MC, de Vries JJJ, Scheffer HJ, van den Tol PMP, Meijerink MR. Transcatheter CT Hepatic Arteriography Compared with Conventional CT Fluoroscopy Guidance in Percutaneous Thermal Ablation to Treat Colorectal Liver Metastases: A Single-Center Comparative Analysis of 2 Historical Cohorts. J Vasc Interv Radiol 2020;31:1772-83. [PMID: 32981819 DOI: 10.1016/j.jvir.2020.05.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
108 Ruers T, Punt C, Van Coevorden F, Pierie JP, Borel-Rinkes I, Ledermann JA, Poston G, Bechstein W, Lentz MA, Mauer M. Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004). Ann Oncol. 2012;23:2619-2626. [PMID: 22431703 DOI: 10.1093/annonc/mds053] [Cited by in Crossref: 241] [Cited by in F6Publishing: 207] [Article Influence: 24.1] [Reference Citation Analysis]
109 Frühling P, Nilsson A, Duraj F, Haglund U, Norén A. Single-center nonrandomized clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) ablation of liver tumors in humans: Short to mid-term results. Eur J Surg Oncol 2017;43:751-7. [PMID: 28109674 DOI: 10.1016/j.ejso.2016.12.004] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
110 Biederman DM, Titano JJ, Bishay VL, Durrani RJ, Dayan E, Tabori N, Patel RS, Nowakowski FS, Fischman AM, Kim E. Radiation Segmentectomy versus TACE Combined with Microwave Ablation for Unresectable Solitary Hepatocellular Carcinoma Up to 3 cm: A Propensity Score Matching Study. Radiology 2017;283:895-905. [DOI: 10.1148/radiol.2016160718] [Cited by in Crossref: 45] [Cited by in F6Publishing: 31] [Article Influence: 9.0] [Reference Citation Analysis]
111 Zhou Y, Yang Y, Zhou B, Wang Z, Zhu R, Chen X, Ouyang J, Li Q, Zhou J. Challenges Facing Percutaneous Ablation in the Treatment of Hepatocellular Carcinoma: Extension of Ablation Criteria. J Hepatocell Carcinoma 2021;8:625-44. [PMID: 34189133 DOI: 10.2147/JHC.S298709] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
112 Tam HH, Al-nahhas A. Treatment of liver tumours with yttrium radioembolisation. Clin Transl Imaging 2014;2:165-82. [DOI: 10.1007/s40336-013-0046-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
113 Murphy KP, Maher MM, O'connor OJ. Abdominal Ablation Techniques. American Journal of Roentgenology 2015;204:W495-502. [DOI: 10.2214/ajr.14.13222] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
114 Young S, Rivard M, Kimyon R, Sanghvi T. Accuracy of liver ablation zone prediction in a single 2450 MHz 100 Watt generator model microwave ablation system: An in human study. Diagnostic and Interventional Imaging 2020;101:225-33. [DOI: 10.1016/j.diii.2019.10.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
115 Mauri G, Solbiati L, Orsi F, Monfardini L. Thermal Ablation of Liver Tumours: The Crucial Role of 3D Imaging. Cardiovasc Intervent Radiol 2020;43:1416-7. [PMID: 32556608 DOI: 10.1007/s00270-020-02560-z] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
116 Hickey R, Vouche M, Sze DY, Hohlastos E, Collins J, Schirmang T, Memon K, Ryu RK, Sato K, Chen R, Gupta R, Resnick S, Carr J, Chrisman HB, Nemcek AA Jr, Vogelzang RL, Lewandowski RJ, Salem R. Cancer concepts and principles: primer for the interventional oncologist-part II. J Vasc Interv Radiol 2013;24:1167-88. [PMID: 23810312 DOI: 10.1016/j.jvir.2013.04.023] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
117 Moche M, Busse H, Futterer JJ, Hinestrosa CA, Seider D, Brandmaier P, Kolesnik M, Jenniskens S, Blanco Sequeiros R, Komar G, Pollari M, Eibisberger M, Portugaller HR, Voglreiter P, Flanagan R, Mariappan P, Reinhardt M. Clinical evaluation of in silico planning and real-time simulation of hepatic radiofrequency ablation (ClinicIMPPACT Trial). Eur Radiol 2020;30:934-42. [DOI: 10.1007/s00330-019-06411-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
118 Meloni MF, Francica G, Chiang J, Coltorti A, Danzi R, Laeseke PF. Use of Contrast-Enhanced Ultrasound in Ablation Therapy of HCC: Planning, Guiding, and Assessing Treatment Response. J Ultrasound Med 2021;40:879-94. [PMID: 32936485 DOI: 10.1002/jum.15471] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
119 Cassinotto C, Denys A, Gay F, Duran R, Hocquelet A, Piron L, Guiu B. Radiofrequency Ablation of Liver Tumors: No Difference in the Ablation Zone Volume Between Cirrhotic and Healthy Liver. Cardiovasc Intervent Radiol 2018;41:905-11. [DOI: 10.1007/s00270-018-1898-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
120 Turtulici G, Orlandi D, Dedone G, Mauri G, Fasciani A, Sirito R, Silvestri E. Ultrasound-guided transvaginal radiofrequency ablation of uterine fibroids assisted by virtual needle tracking system: a preliminary study. International Journal of Hyperthermia 2018;35:97-104. [DOI: 10.1080/02656736.2018.1479778] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
121 Gurusamy K, Corrigan N, Croft J, Twiddy M, Morris S, Woodward N, Bandula S, Hochhauser D, Napp V, Pullan A, Jakowiw N, Prasad R, Damink SO, van Laarhoven CJHM, de Wilt JHW, Brown J, Davidson BR. Liver resection surgery versus thermal ablation for colorectal LiVer MetAstases (LAVA): study protocol for a randomised controlled trial. Trials. 2018;19:105. [PMID: 29439711 DOI: 10.1186/s13063-018-2499-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
122 Babawale SN, Jensen TM, Frøkjær JB. Long-term survival following radiofrequency ablation of colorectal liver metastases: A retrospective study. World J Gastrointest Surg 2015; 7(3): 33-38 [PMID: 25848490 DOI: 10.4240/wjgs.v7.i3.33] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
123 Gervais DA, Arellano RS. Percutaneous tumor ablation for hepatocellular carcinoma. AJR Am J Roentgenol. 2011;197:789-794. [PMID: 21940565 DOI: 10.2214/ajr.11.7656] [Cited by in Crossref: 46] [Cited by in F6Publishing: 15] [Article Influence: 4.2] [Reference Citation Analysis]
124 Bernard V, Andrašina T, Červinka D, Martiš J, Procházka P, Mornstein V, Válek V. A Thermographic Comparison of Irreversible Electroporation and Radiofrequency Ablation. IRBM 2017;38:26-33. [DOI: 10.1016/j.irbm.2016.11.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
125 Bareck E, Ba-Ssalamah A, Brodowicz T, Eisterer W, Häfner M, Högenauer C, Kastner U, Kühr T, Längle F, Liegl-Atzwanger B. Gastrointestinal stromal tumors: diagnosis, therapy and follow-up care in Austria. Wien Med Wochenschr. 2013;163:137-152. [PMID: 23508516 DOI: 10.1007/s10354-013-0187-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
126 Shrimal A, Prasanth M, Kulkarni AV. Interventional radiological treatment of hepatocellular carcinoma: an update. Indian J Surg 2012;74:91-9. [PMID: 23372313 DOI: 10.1007/s12262-011-0377-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
127 Kollmann D, Selzner N, Selzner M. Bridging to liver transplantation in HCC patients. Langenbecks Arch Surg. 2017;402:863-871. [PMID: 28755240 DOI: 10.1007/s00423-017-1609-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
128 Maeda M, Saeki I, Sakaida I, Aikata H, Araki Y, Ogawa C, Kariyama K, Nouso K, Kitamoto M, Kobashi H, Sato S, Shibata H, Joko K, Takaki S, Takabatake H, Tsutsui A, Takaguchi K, Tomonari T, Nakamura S, Nagahara T, Hiraoka A, Matono T, Koda M, Mandai M, Mannami T, Mitsuda A, Moriya T, Yabushita K, Tani J, Yagi T, Yamasaki T. Complications after Radiofrequency Ablation for Hepatocellular Carcinoma: A Multicenter Study Involving 9,411 Japanese Patients. Liver Cancer. 2020;9:50-62. [PMID: 32071909 DOI: 10.1159/000502744] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
129 Keane FK, Tanguturi SK, Zhu AX, Dawson LA, Hong TS. Radiotherapy for liver tumors. Hepat Oncol 2015;2:133-46. [PMID: 30190993 DOI: 10.2217/hep.15.7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
130 Yang S, Li X. A commentary on "The prognosis of radiofrequency ablation versus hepatic resection for patients with colorectal liver metastases: A systematic review and meta-analysis based on 22 studies" [Int. J. Surg. 87 (2021) 105896]. Int J Surg 2021;89:105954. [PMID: 33895347 DOI: 10.1016/j.ijsu.2021.105954] [Reference Citation Analysis]
131 Keane FK, Hong TS. Role and Future Directions of External Beam Radiotherapy for Primary Liver Cancer. Cancer Control 2017;24:1073274817729242. [PMID: 28975835 DOI: 10.1177/1073274817729242] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
132 Breen DJ, Lencioni R. Image-guided ablation of primary liver and renal tumours. Nat Rev Clin Oncol. 2015;12:175-186. [PMID: 25601446 DOI: 10.1038/nrclinonc.2014.237] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 5.9] [Reference Citation Analysis]
133 Hui TC, Kwan J, Pua U. Advanced Techniques in the Percutaneous Ablation of Liver Tumours. Diagnostics (Basel) 2021;11:585. [PMID: 33805107 DOI: 10.3390/diagnostics11040585] [Reference Citation Analysis]
134 Puijk RS, Ruarus AH, Vroomen LGPH, van Tilborg AAJM, Scheffer HJ, Nielsen K, de Jong MC, de Vries JJJ, Zonderhuis BM, Eker HH, Kazemier G, Verheul H, van der Meijs BB, van Dam L, Sorgedrager N, Coupé VMH, van den Tol PMP, Meijerink MR; COLLISION Trial Group. Colorectal liver metastases: surgery versus thermal ablation (COLLISION) - a phase III single-blind prospective randomized controlled trial. BMC Cancer 2018;18:821. [PMID: 30111304 DOI: 10.1186/s12885-018-4716-8] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 11.5] [Reference Citation Analysis]
135 Dijkstra M, Nieuwenhuizen S, Puijk RS, Timmer FEF, Geboers B, Schouten EAC, Opperman J, Scheffer HJ, de Vries JJJ, Versteeg KS, Lissenberg-Witte BI, Meijerink MR, van den Tol MP. Repeat Local Treatment of Recurrent Colorectal Liver Metastases, the Role of Neoadjuvant Chemotherapy: An Amsterdam Colorectal Liver Met Registry (AmCORE) Based Study. Cancers (Basel) 2021;13:4997. [PMID: 34638481 DOI: 10.3390/cancers13194997] [Reference Citation Analysis]
136 Zhu Q, Shen Y, Zhang A, Xu LX. Numerical study of the influence of water evaporation on radiofrequency ablation. Biomed Eng Online 2013;12:127. [PMID: 24325296 DOI: 10.1186/1475-925X-12-127] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
137 Staal FCR, Taghavi M, van der Reijd DJ, Gomez FM, Imani F, Klompenhouwer EG, Meek D, Roberti S, de Boer M, Lambregts DMJ, Beets-Tan RGH, Maas M. Predicting local tumour progression after ablation for colorectal liver metastases: CT-based radiomics of the ablation zone. Eur J Radiol 2021;141:109773. [PMID: 34022475 DOI: 10.1016/j.ejrad.2021.109773] [Reference Citation Analysis]
138 Collettini F, Schreiber N, Schnapauff D, Denecke T, Wust P, Schott E, Hamm B, Gebauer B. CT-guided high-dose-rate brachytherapy of unresectable hepatocellular carcinoma. Strahlenther Onkol 2015;191:405-12. [DOI: 10.1007/s00066-014-0781-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
139 Feldkamp J, Grünwald F, Luster M, Lorenz K, Vorländer C, Führer D. Non-Surgical and Non-Radioiodine Techniques for Ablation of Benign Thyroid Nodules: Consensus Statement and Recommendation. Exp Clin Endocrinol Diabetes 2020;128:687-92. [PMID: 31910466 DOI: 10.1055/a-1075-2025] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
140 Widmann G, Schullian P, Bale R. [Radiofrequency ablation of hepatocellular carcinoma]. Wien Med Wochenschr 2013;163:132-6. [PMID: 23515886 DOI: 10.1007/s10354-013-0176-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
141 Tselis N, Chatzikonstantinou G, Kolotas C, Milickovic N, Baltas D, Zamboglou N. Computed tomography-guided interstitial high dose rate brachytherapy for centrally located liver tumours: a single institution study. Eur Radiol 2013;23:2264-70. [PMID: 23515917 DOI: 10.1007/s00330-013-2816-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
142 Xuan M, Zhou F, Ding Y, Zhu Q, Dong J, Zhou H, Cheng J, Jiang X, Wu P. Diagnostic accuracy of contrast-enhanced ultrasound in assessing the therapeutic response to radio frequency ablation for liver tumors: systematic review and meta-analysis. Surg Endosc 2018;32:2067-75. [DOI: 10.1007/s00464-017-5903-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
143 Bajpai S, Kambadakone A, Guimaraes AR, Arellano RS, Gervais DA, Sahani D. Image-guided Treatment in the Hepatobiliary System: Role of Imaging in Treatment Planning and Posttreatment Evaluation. RadioGraphics 2015;35:1393-418. [DOI: 10.1148/rg.2015140281] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
144 Collettini F, Singh A, Schnapauff D, Powerski MJ, Denecke T, Wust P, Hamm B, Gebauer B. Computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of metastases adjacent to the liver hilum. Eur J Radiol 2013;82:e509-14. [PMID: 23791521 DOI: 10.1016/j.ejrad.2013.04.046] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
145 Minami Y, Nishida N, Kudo M. Radiofrequency ablation of liver metastasis: potential impact on immune checkpoint inhibitor therapy. Eur Radiol. 2019;29:5045-5051. [PMID: 30963271 DOI: 10.1007/s00330-019-06189-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
146 Chang W, Lee JM, Lee DH, Yoon JH, Kim YJ, Yoon JH, Han JK. Comparison of switching bipolar ablation with multiple cooled wet electrodes and switching monopolar ablation with separable clustered electrode in treatment of small hepatocellular carcinoma: A randomized controlled trial. PLoS One 2018;13:e0192173. [PMID: 29420589 DOI: 10.1371/journal.pone.0192173] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
147 Greco C. The Uncertain Presence: Experiences of Living with Metastatic Breast Cancer. Med Anthropol 2021;:1-12. [PMID: 34187222 DOI: 10.1080/01459740.2021.1941003] [Reference Citation Analysis]
148 Xu Y, Heberlein WE, Mahmood M, Orza AI, Karmakar A, Mustafa T, Biris AR, Casciano D, Biris AS. Progress in materials for thermal ablation of cancer cells. J Mater Chem 2012;22:20128. [DOI: 10.1039/c2jm32792a] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
149 Sivasubramanian M, Chuang YC, Chen NT, Lo LW. Seeing Better and Going Deeper in Cancer Nanotheranostics. Int J Mol Sci 2019;20:E3490. [PMID: 31315232 DOI: 10.3390/ijms20143490] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
150 Zhang Z, Shao G, Zheng J, Wen S, Zeng H, Hao W, Luo J, Guo L. Electromagnetic navigation to assist with computed tomography-guided thermal ablation of liver tumors. Minim Invasive Ther Allied Technol 2020;29:275-82. [PMID: 31393746 DOI: 10.1080/13645706.2019.1649699] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
151 Crocetti L, Bargellini I, Cioni R. Loco-regional treatment of HCC: current status. Clin Radiol. 2017;72:626-635. [PMID: 28258743 DOI: 10.1016/j.crad.2017.01.013] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 7.0] [Reference Citation Analysis]
152 Wiggermann P, Puls R, Vasilj A, Sieroń D, Schreyer AG, Jung EM, Wawrzynek W, Stroszczynski C. Thermal ablation of unresectable liver tumors: factors associated with partial ablation and the impact on long-term survival. Med Sci Monit 2012;18:CR88-92. [PMID: 22293882 DOI: 10.12659/msm.882463] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
153 Crocetti L, Amabile C, Scalise P, Tosoratti N, Bozzi E, Rossi P, Cervelli R, Cassarino S, Cioni R. Predicting the coagulation volume induced by microwave ablation of hepatocellular carcinoma: the role of deposited energy, ex-vivo bovine liver charts and central hyperdense area on post-treatment CT. Int J Hyperthermia 2021;38:1486-94. [PMID: 34927518 DOI: 10.1080/02656736.2021.1986642] [Reference Citation Analysis]
154 van Tilborg AA, Scheffer HJ, de Jong MC, Vroomen LG, Nielsen K, van Kuijk C, van den Tol PM, Meijerink MR. MWA Versus RFA for Perivascular and Peribiliary CRLM: A Retrospective Patient- and Lesion-Based Analysis of Two Historical Cohorts. Cardiovasc Intervent Radiol. 2016;39:1438-1446. [PMID: 27387188 DOI: 10.1007/s00270-016-1413-3] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
155 Ruarus A, Vroomen L, Puijk R, Scheffer H, Zonderhuis B, Kazemier G, van den Tol M, Berger F, Meijerink M. Irreversible Electroporation in Hepatopancreaticobiliary Tumours. Can Assoc Radiol J 2018;69:38-50. [DOI: 10.1016/j.carj.2017.10.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
156 Puijk RS, Ziedses des Plantes V, Nieuwenhuizen S, Ruarus AH, Vroomen LGPH, de Jong MC, Geboers B, Hoedemaker-Boon CJ, Thöne-Passchier DH, Gerçek CC, de Vries JJJ, van den Tol PMP, Scheffer HJ, Meijerink MR. Propofol Compared to Midazolam Sedation and to General Anesthesia for Percutaneous Microwave Ablation in Patients with Hepatic Malignancies: A Single-Center Comparative Analysis of Three Historical Cohorts. Cardiovasc Intervent Radiol 2019;42:1597-608. [PMID: 31243542 DOI: 10.1007/s00270-019-02273-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
157 Hu XY, Li L, Wu HT, Liu Y, Wang BD, Tang Y. Serum miR-130b level, an ideal marker for monitoring the recurrence and prognosis of primary hepatocellular carcinoma after radiofrequency ablation treatment. Pathol Res Pract 2018;214:1655-60. [PMID: 30153957 DOI: 10.1016/j.prp.2018.08.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
158 Rim CH, Lee HY, Kim JS, Kim H. Radiofrequency ablation and stereotactic body radiotherapy for hepatocellular carcinoma: should they clash or reconcile? Int J Radiat Biol 2021;97:111-9. [PMID: 33253598 DOI: 10.1080/09553002.2021.1857453] [Reference Citation Analysis]
159 Mauer K, O’Kelley R, Podda N, Flanagan S, Gadani S. New treatment modalities for hepatocellular cancer. Curr Gastroenterol Rep. 2015;17:442. [PMID: 25869473 DOI: 10.1007/s11894-015-0442-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
160 Vera R, González-Flores E, Rubio C, Urbano J, Valero Camps M, Ciampi-Dopazo JJ, Orcajo Rincón J, Morillo Macías V, Gomez Braco MA, Suarez-Artacho G. Multidisciplinary management of liver metastases in patients with colorectal cancer: a consensus of SEOM, AEC, SEOR, SERVEI, and SEMNIM.Clin Transl Oncol. 2020;22:647-662. [PMID: 31359336 DOI: 10.1007/s12094-019-02182-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
161 Tinguely P, Paolucci I, Ruiter SJS, Weber S, de Jong KP, Candinas D, Freedman J, Engstrand J. Stereotactic and Robotic Minimally Invasive Thermal Ablation of Malignant Liver Tumors: A Systematic Review and Meta-Analysis. Front Oncol 2021;11:713685. [PMID: 34631539 DOI: 10.3389/fonc.2021.713685] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
162 Cortis K, Degiorgio S, Cannataci C, Miraglia R. Balloon-Occluded Microwave Ablation: A Potential Therapeutic Option in Liver Lesions Bearing Close Proximity to Major Hepatic and/or Portal Veins. Cardiovasc Intervent Radiol 2017;40:1962-5. [PMID: 28593396 DOI: 10.1007/s00270-017-1723-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
163 Izzo F, Granata V, Grassi R, Fusco R, Palaia R, Delrio P, Carrafiello G, Azoulay D, Petrillo A, Curley SA. Radiofrequency Ablation and Microwave Ablation in Liver Tumors: An Update. Oncologist 2019;24:e990-e1005. [PMID: 31217342 DOI: 10.1634/theoncologist.2018-0337] [Cited by in Crossref: 75] [Cited by in F6Publishing: 63] [Article Influence: 25.0] [Reference Citation Analysis]
164 Iezzi R, Pompili M, Posa A, Carchesio F, Siciliano M, Annicchiarico BE, Agnes S, Giuliante F, Garcovich M, Cerrito L, Ponziani FR, Basso M, Cassano A, Rapaccini GL, De Gaetano AM, Gasbarrini A, Manfredi R; HepatoCATT Study Group for the Multidisciplinary Management of HCC. Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? Eur J Radiol 2019;114:32-7. [PMID: 31005173 DOI: 10.1016/j.ejrad.2019.02.030] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
165 Woo HY, Kim DY, Heo J, Kim CW, Kim S, Yoon KT, Lim W, Hong YM, Won JY, Lee S, Han KH, Cho M. Effect of yttrium-90 radioembolization on outcomes in Asian patients with early to advanced stage hepatocellular carcinoma: Outcome after radioembolization for HCC. Hepatol Res 2017;47:387-97. [DOI: 10.1111/hepr.12759] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
166 Derek E, Matsuoka L, Alexopoulos S, Fedenko A, Genyk Y, Selby R. Combined surgical resection and radiofrequency ablation as treatment for metastatic ocular melanoma. Surg Today 2013;43:367-71. [PMID: 22766897 DOI: 10.1007/s00595-012-0244-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
167 Tanaka T, Isfort P, Braunschweig T, Westphal S, Woitok A, Penzkofer T, Bruners P, Kichikawa K, Schmitz-Rode T, Mahnken AH. Superselective particle embolization enhances efficacy of radiofrequency ablation: effects of particle size and sequence of action. Cardiovasc Intervent Radiol. 2013;36:773-782. [PMID: 23070107 DOI: 10.1007/s00270-012-0497-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
168 Conci S, D'Onofrio M, Bianco A, Campagnaro T, Martone E, De Bellis M, Longo C, Dedoni S, Vittoria D'Addetta M, Ciangherotti A, Pedrazzani C, Dalbeni A, Campagnola P, Mansueto G, Guglielmi A, Ruzzenente A. Ablation Difficulty Score: Proposal of a new tool to predict success rate of percutaneous ablation for hepatocarcinoma. Eur J Radiol 2022;146:110097. [PMID: 34896959 DOI: 10.1016/j.ejrad.2021.110097] [Reference Citation Analysis]
169 Molvar C, Lewandowski R. Yttrium-90 Radioembolization of Hepatocellular Carcinoma-Performance, Technical Advances, and Future Concepts. Semin Intervent Radiol 2015;32:388-97. [PMID: 26622103 DOI: 10.1055/s-0035-1564704] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
170 Meijerink MR, Ruarus AH, Vroomen LGPH, Puijk RS, Geboers B, Nieuwenhuizen S, van den Bemd BAT, Nielsen K, de Vries JJJ, van Lienden KP, Lissenberg-Witte BI, van den Tol MP, Scheffer HJ. Irreversible Electroporation to Treat Unresectable Colorectal Liver Metastases (COLDFIRE-2): A Phase II, Two-Center, Single-Arm Clinical Trial. Radiology 2021;299:470-80. [PMID: 33724066 DOI: 10.1148/radiol.2021203089] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
171 Young S, Golzarian J. Locoregional Therapies in the Treatment of 3- to 5-cm Hepatocellular Carcinoma: Critical Review of the Literature. AJR Am J Roentgenol 2020;215:223-34. [PMID: 32255691 DOI: 10.2214/AJR.19.22098] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
172 Park SI, Kim IJ, Lee SJ, Shin MW, Shin WS, Chung YE, Kim GM, Kim MD, Won JY, Lee do Y, Choi JS, Han KH. Angled Cool-Tip Electrode for Radiofrequency Ablation of Small Superficial Subcapsular Tumors in the Liver: A Feasibility Study. Korean J Radiol 2016;17:742-9. [PMID: 27587963 DOI: 10.3348/kjr.2016.17.5.742] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
173 Fumarola EM, Ierardi AM, Biondetti P, Savoldi AP, Grillo P, Gorga G, Coppola A, Carrafiello G. Follow-up of percutaneous microwave (MW) ablation of hepatic lesion: predictive value of CT at 24-h compared with CT at 1 month. Med Oncol 2020;37:41. [PMID: 32266568 DOI: 10.1007/s12032-020-01364-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
174 Puijk RS, Dijkstra M, van den Bemd BAT, Ruarus AH, Nieuwenhuizen S, Geboers B, Timmer FEF, Schouten EAC, de Vries JJJ, van der Meijs BB, Nielsen K, Swijnenburg RJ, van den Tol MP, Versteeg KS, Lissenberg-Witte BI, Scheffer HJ, Meijerink MR. Improved Outcomes of Thermal Ablation for Colorectal Liver Metastases: A 10-Year Analysis from the Prospective Amsterdam CORE Registry (AmCORE). Cardiovasc Intervent Radiol 2022. [PMID: 35585138 DOI: 10.1007/s00270-022-03152-9] [Reference Citation Analysis]
175 Poulou LS, Botsa E, Thanou I, Ziakas PD, Thanos L. Percutaneous microwave ablation vs radiofrequency ablation in the treatment of hepatocellular carcinoma. World J Hepatol 2015; 7(8): 1054-1063 [PMID: 26052394 DOI: 10.4254/wjh.v7.i8.1054] [Cited by in Crossref: 154] [Cited by in F6Publishing: 121] [Article Influence: 22.0] [Reference Citation Analysis]
176 Revel-Mouroz P, Otal P, Jaffro M, Petermann A, Meyrignac O, Rabinel P, Mokrane FZ. Other non-surgical treatments for liver cancer. Rep Pract Oncol Radiother 2017;22:181-92. [PMID: 28490991 DOI: 10.1016/j.rpor.2017.02.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]